Clinical trial

T-Cell Therapy for Advanced Breast Cancer

NCT02792114

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2016-06-01

PhasePHASE1

Study timeline

Study start (actual)2016-06-01Date precision: month

Registry last updated2026-07-16

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Metastatic HER2-negative Breastunresolved

Interventions

CyclophosphamideDRUG · verified · RxNorm: cyclophosphamide

Mesothelin-targeted T cellsBIOLOGICAL

Sponsors & collaborators

Memorial Sloan Kettering Cancer Centerlead sponsor

United States Department of Defensecollaborator

Mapped research locations

New YorkNew York, United States1 CommackNew York, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02792114 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.